Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income	$ (2,929,344)	$ (3,885,852)	$ (6,914,752)	$ 2,930,847
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Stock-based compensation expense			171,106	2,773,451
Stock-based 401K company common match			19,967	25,244
Depreciation expense			7,805	62,706
Amortization of the right-to-use asset			41,800	0
Bargain purchase gain from merger	0	(209,449)	0	(11,939,331)
Changes in assets and liabilities:
Prepaid expenses and other assets			(198,184)	157,273
Accounts payable			(105,193)	(1,157,171)
Accrued expenses			96,718	(292,678)
Restructuring reserve			(371,323)	(786,396)
Cash payments for expenses:
Payments made for operating lease			(15,649)	0
Net cash used in operating activities			(7,267,705)	(8,226,055)
Cash flows from investing activities:
Cash received in reverse merger transaction			0	29,106,512
Net cash provided by investing activities			0	29,106,512
Cash flows from financing activities:
Proceeds from exercise of warrants			70,459	0
Proceeds from issuance of common stock, net of issuance costs			11,970,002	750,000
Net cash provided by financing activities			12,040,461	750,000
Net increase in cash and cash equivalents			4,772,756	21,630,457
Cash and cash equivalents at beginning of period			12,161,739	103,695	$ 103,695
Cash and cash equivalents at end of period	$ 16,934,495	$ 21,734,152	16,934,495	21,734,152	$ 12,161,739
Cash paid for:
Interest			0	606
Supplemental cash flow information:
Conversion of convertible notes and accrued interest into common stock			0	32,953
Consideration in connection with reverse merger transaction			$ 0	$ 15,793,638